Literature DB >> 10490044

Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis.

Y Taché1.   

Abstract

The characterization of corticotropin-releasing factor (CRF) and CRF receptors and the use of specific CRF antagonists have paved the way to establish a key role of brain CRF in the coding of the stress response. CRF injected into the cerebrospinal fluid or the periphery inhibits gastric emptying in various species. The paraventricular nucleus of the hypothalamus and dorsal vagal complex are brain sites of action for CRF. Endogenous brain CRF plays a role in mediating psychological, physical, somatovisceral, and immunological stress-induced delayed gastric emptying in rats. Postoperative gastric ileus is also prevented by peripheral injection of CRF antagonists. Cyclic vomiting syndrome (CVS) is precipitated by stimuli or states associated with stimulation of CRF release, and the resulting endocrine, autonomic, and visceral changes are indicative of central CRF activation. Moreover, empiric pharmacotherapy alleviating CVS symptoms are known experimentally to block CRF release or action. The relevance of central CRF activation in the pathophysiology of CVS deserves further consideration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490044

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Cyclic Vomiting Syndrome.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-10

2.  Cannabinoid hyperemesis: a case series of 98 patients.

Authors:  Douglas A Simonetto; Amy S Oxentenko; Margot L Herman; Jason H Szostek
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 3.  Corticotropin-releasing factor receptors and stress-related alterations of gut motor function.

Authors:  Yvette Taché; Bruno Bonaz
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 4.  Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome.

Authors:  Ana Marissa Lagman-Bartolome; Christine Lay
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

5.  An adult case of cyclic vomiting syndrome successfully responding to valproic acid.

Authors:  Y Nakazato; N Tamura; K Shimazu
Journal:  J Neurol       Date:  2008-05-07       Impact factor: 4.849

6.  Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report.

Authors:  Masayuki Nogi; David Fergusson; John Michael Chua Chiaco
Journal:  Hawaii J Med Public Health       Date:  2014-04

7.  Case of cannabinoid hyperemesis syndrome with long-term follow-up.

Authors:  Jae Myung Cha; Richard A Kozarek; Otto S Lin
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 8.  New treatments for irritable bowel syndrome in women.

Authors:  Mopelola A Adeyemo; Lin Chang
Journal:  Womens Health (Lond)       Date:  2008-11

9.  A survey of emergency department use in patients with cyclic vomiting syndrome.

Authors:  Thangam Venkatesan; Sally Tarbell; Kathleen Adams; Jennifer McKanry; Trish Barribeau; Kathleen Beckmann; Walter J Hogan; Nilay Kumar; B U K Li
Journal:  BMC Emerg Med       Date:  2010-02-24

10.  Recent concepts on cyclic vomiting syndrome in children.

Authors:  Hye Ran Yang
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.